Infarmed evaluates potential co-payment for obesity medications
Infarmed is assessing the possibility of co-payment for obesity treatment medications, announced the Minister of Health on Wednesday, following new recommendations from the WHO regarding the disease. “It must be evaluated by experts and must fall within the guidelines set by the DGS for cases considered severe,” she said ...
